311 related articles for article (PubMed ID: 38399302)
1. Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy.
Yan S; Na J; Liu X; Wu P
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399302
[TBL] [Abstract][Full Text] [Related]
2. A Review on Targeting Nanoparticles for Breast Cancer.
Alqaraghuli HGJ; Kashanian S; Rafipour R
Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
[TBL] [Abstract][Full Text] [Related]
3. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy.
Wei Z; Zhou Y; Wang R; Wang J; Chen Z
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559056
[TBL] [Abstract][Full Text] [Related]
4. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
5. Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer.
Sanjanwala D; Patravale V
Drug Discov Today; 2023 May; 28(5):103550. PubMed ID: 36906220
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y
Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate ligands-directed active tumor targeting of combinatorial chemotherapy/phototherapy-based nanomedicine: A review.
Agwa MM; Elmotasem H; Elsayed H; Abdelsattar AS; Omer AM; Gebreel DT; Mohy-Eldin MS; Fouda MMG
Int J Biol Macromol; 2023 Jun; 239():124294. PubMed ID: 37004933
[TBL] [Abstract][Full Text] [Related]
8. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
9. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
[TBL] [Abstract][Full Text] [Related]
10. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in biological strategies for targeted drug delivery.
Ye X; Yang D
Cardiovasc Hematol Disord Drug Targets; 2009 Sep; 9(3):206-21. PubMed ID: 19817715
[TBL] [Abstract][Full Text] [Related]
12. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
13. Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges.
Toporkiewicz M; Meissner J; Matusewicz L; Czogalla A; Sikorski AF
Int J Nanomedicine; 2015; 10():1399-414. PubMed ID: 25733832
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based drug delivery systems targeting cancer cell surfaces.
Hong L; Li W; Li Y; Yin S
RSC Adv; 2023 Jul; 13(31):21365-21382. PubMed ID: 37465582
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-Based Smart Targeting and Spatial Trigger-Response Drug-Delivery Systems for Anticancer Therapy.
Park D; Lee SJ; Park JW
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255292
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Mediated Targeted Delivery of Therapeutics: An Update.
Catuogno S; Esposito CL; de Franciscis V
Pharmaceuticals (Basel); 2016 Nov; 9(4):. PubMed ID: 27827876
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in dual-ligand targeted nanocarriers for cancer therapy.
Khan N; Ruchika ; Dhritlahre RK; Saneja A
Drug Discov Today; 2022 Aug; 27(8):2288-2299. PubMed ID: 35439614
[TBL] [Abstract][Full Text] [Related]
18. Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.
Jurczyk M; Jelonek K; Musiał-Kulik M; Beberok A; Wrześniok D; Kasperczyk J
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802531
[TBL] [Abstract][Full Text] [Related]
19. Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment.
David A
Adv Drug Deliv Rev; 2017 Sep; 119():120-142. PubMed ID: 28506743
[TBL] [Abstract][Full Text] [Related]
20. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems.
Yoo J; Park C; Yi G; Lee D; Koo H
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31072061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
